Insider · CIK 0001945612
Ann-Louise Batchelor
Files at VNRX (VOLITIONRX LTD). First filing -, latest -.
Ann-Louise Batchelor files SEC Form 4 as officer at VNRX (VOLITIONRX LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ann-Louise Batchelor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +142,000 | $0.00 | $0 | 324,072 | Feb 27, 2026 |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +33,900 | $0.00 | $0 | 182,072 | Jan 23, 2026 |
| Oct 4, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -6,110 | $0.65 | $3,959 | 148,172 | Oct 7, 2025 |
| Sep 28, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -5,604 | $0.61 | $3,390 | 154,282 | Sep 30, 2025 |
| Aug 15, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +27,400 | $0.00 | $0 | 159,886 | Aug 19, 2025 |
| Aug 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -8,620 | $0.64 | $5,517 | 132,486 | Aug 5, 2025 |
| Jul 1, 2025 | VNRX VOLITIONRX LTD | FTax withholding Common Stock | -6,177 | $0.77 | $4,743 | 141,106 | Jul 3, 2025 |
| Jun 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +18,341 | $0.00 | $0 | 147,283 | Jun 3, 2025 |
| Mar 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +14,233 | $0.00 | $0 | 128,942 | Mar 4, 2025 |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Spouse | -40,000 | - | - | 0 | Jan 31, 2025 |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Spouse | +40,000 | - | - | 40,000 | Jan 31, 2025 |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +13,143 | $0.00 | $0 | 114,709 | Dec 3, 2024 |
Questions about Ann-Louise Batchelor
Answered from the filings on this page, as of the latest one.
Is Ann-Louise Batchelor buying or selling?
Ann-Louise Batchelor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ann-Louise Batchelor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ann-Louise Batchelor has 0.
Where does Ann-Louise Batchelor file Form 4?
Ann-Louise Batchelor has filed Form 4 at VNRX (VOLITIONRX LTD) as Group Chief Marketing Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.